IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockade

Authors: Valenzuela-Cardenas, Miriam, Fisher, Carrie, Bartee, Mee Y., Bartee, Eric

Source: In Molecular Therapy: Oncology 19 September 2024 32(3)

The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors

Authors: Gowan, Cody C., Bartee, Mee Y., Flores, Erica, Aksoy, Bulent A., Templeton, Conor, Baillie, Kati, Happe, Myroslawa, Bartee, Eric

Source: Journal of immunotherapy. 46(1):1-4

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178862138.0x000001&indx=1&recIds=ETOCvdc_100178862138.0x000001

Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING

Authors: Heath, Blake R., Gong, Wang, Taner, Hülya F., Broses, Luke, Okuyama, Kohei, Cheng, Wanqing, Jin, Max, Fitzsimonds, Zackary R., Manousidaki, Andriana, Wu, Yuesong, Zhang, Shaoping, Wen, Haitao, Chinn, Steven B., Bartee, Eric, Xie, Yuying, Moon, James J., Lei, Yu Leo

Source: In Cell Reports 25 April 2023 42(4)

Interleukin-23 receptor signaling by interleukin-39 potentiates T cell pathogenicity in acute graft-versus-host disease

Authors: Bastian, David, Sui, Xiaohui, Nguyen, Hung Dang, Wu, Yongxia, Schutt, Steven, Tian, Linlu, Sofi, Mohammed Hanief, Liu, Yuejun, Martin, Paul, Bartee, Eric, Yu, Xue-Zhong ^*

Source: In American Journal of Transplantation November 2021 21(11):3538-3549

Regional immune mechanisms enhance efficacy of an autologous cellular cancer vaccine with intraperitoneal administration.

Authors: Marwedel, Ben, Medina, Lorél Y., De May, Henning, Adogla, Joshua E., Kennedy, Ellie, Flores, Erica, Lim, Eunju, Adams, Sarah, Bartee, Eric, Serda, Rita E.

Source: OncoImmunology; 2024, Vol. 13 Issue 1, p1-15, 15p

Subject Terms: TOLL-like receptor agonists, MYELOID cells, IMMUNE checkpoint inhibitors, VACCINE effectiveness, GASTROINTESTINAL cancer, DNA mismatch repair

Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic Virotherapy

Authors: Flores, Erica B., Bartee, Eric

Source: In Molecular Therapy - Oncolytics 16 December 2020 19:323-331

Syncytia Formation in Oncolytic Virotherapy

Authors: Burton, Chase, Bartee, Eric

Source: In Molecular Therapy - Oncolytics 20 December 2019 15:131-139

Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy

Authors: Bartee, Mee, Dryja, Parker C., Bartee, Eric

Source: Journal for immunotherapy of cancer. 7(1):1-8

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186496696.0x000001&indx=1&recIds=ETOCvdc_100186496696.0x000001

Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells

Authors: Bartee, Mee Y., Dunlap, Katherine M., Bartee, Eric

Source: In Clinical Lymphoma Myeloma and Leukemia April 2016 16(4):203-212

Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice

Authors: Bartee, Eric, Bartee, Mee Y, Bogen, Bjarne, Yu, Xue-Zhong

Source: In Molecular Therapy - Oncolytics 2016 3

Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection

Authors: Thomas, Raquela J., Bartee, Mee Y., Valenzuela-Cardenas, Miriam, Bartee, Eric

Source: In Molecular Therapy - Oncolytics 21 September 2023 30:316-319

Method for treating or preventing graft versus host disease

Cytokine synergy: An underappreciated contributor to innate anti-viral immunity

Authors: Bartee, Eric, McFadden, Grant

Source: In Cytokine September 2013 63(3):237-240

Selective Purging of Human Multiple Myeloma Cells from Autologous Stem Cell Transplantation Grafts using Oncolytic Myxoma Virus

Authors: Bartee, Eric, Chan, Winnie M., Moreb, Jan S., Cogle, Christopher R., McFadden, Grant

Source: In Biology of Blood and Marrow Transplantation October 2012 18(10):1540-1551

Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro

Authors: Madlambayan, Gerard J., Bartee, Eric, Kim, Manbok, Rahman, Masmudur M., Meacham, Amy, Scott, Edward W., McFadden, Grant, Cogle, Christopher R.

Source: In Leukemia Research May 2012 36(5):619-624

Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells

Authors: Villa, Nancy Y., Bartee, Eric, Mohamed, Mohamed R., Rahman, Masmudur M., Barrett, John W., McFadden, Grant

Source: In Virology 2010 401(2):266-279

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade

Authors: Bartee, Eric, Li, Zihai

Source: Experimental hematology & oncology. 6(1):1-3

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100133601123.0x000001&indx=1&recIds=ETOCvdc_100133601123.0x000001

Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-β

Authors: Bartee, Eric, McFadden, Grant

Source: In Cytokine 2009 47(3):199-205

Tumor necrosis factor and interferon: cytokines in harmony

Authors: Bartee, Eric, Mohamed, Mohamed R, McFadden, Grant

Source: In Current Opinion in Microbiology 2008 11(4):378-383

Navigating a complex dance: the interplay between RNA-binding proteins and T cells in oral epithelial plasticity

Authors: Vijayakumar, Anitha, Vasudevan, Sekar, John, Samu, Ozbun, Michelle A., Bartee, Eric, Palanisamy, Viswanathan

Source: Immunometabolism; January 2025, Vol. 7 Issue: 1 pe00054-e00054, 1p